Observational studyJapanese journal of clinical oncology2026
Safety and effectiveness of selpercatinib in patients with RET fusion-positive non-small cell lung cancer in real-world clinical practice: a postmarketing study in Japan.
Yucherng Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.